Ohki Healthcare HoldingsLtd (TSE:3417) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Ohki Healthcare Holdings Co.,Ltd.'s (TSE:3417) stock was strong after they recently reported robust earnings. However, our analysis suggests that shareholders may be missing some factors that indicate the earnings result was not as good as it looked.

Our free stock report includes 3 warning signs investors should be aware of before investing in Ohki Healthcare HoldingsLtd. Read for free now.
earnings-and-revenue-history
TSE:3417 Earnings and Revenue History May 25th 2025
Advertisement

Zooming In On Ohki Healthcare HoldingsLtd's Earnings

As finance nerds would already know, the accrual ratio from cashflow is a key measure for assessing how well a company's free cash flow (FCF) matches its profit. To get the accrual ratio we first subtract FCF from profit for a period, and then divide that number by the average operating assets for the period. This ratio tells us how much of a company's profit is not backed by free cashflow.

As a result, a negative accrual ratio is a positive for the company, and a positive accrual ratio is a negative. While having an accrual ratio above zero is of little concern, we do think it's worth noting when a company has a relatively high accrual ratio. That's because some academic studies have suggested that high accruals ratios tend to lead to lower profit or less profit growth.

Over the twelve months to March 2025, Ohki Healthcare HoldingsLtd recorded an accrual ratio of 0.43. Statistically speaking, that's a real negative for future earnings. And indeed, during the period the company didn't produce any free cash flow whatsoever. Even though it reported a profit of JP¥2.64b, a look at free cash flow indicates it actually burnt through JP¥12b in the last year. We saw that FCF was JP¥7.2b a year ago though, so Ohki Healthcare HoldingsLtd has at least been able to generate positive FCF in the past. One positive for Ohki Healthcare HoldingsLtd shareholders is that it's accrual ratio was significantly better last year, providing reason to believe that it may return to stronger cash conversion in the future. As a result, some shareholders may be looking for stronger cash conversion in the current year.

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Ohki Healthcare HoldingsLtd.

Our Take On Ohki Healthcare HoldingsLtd's Profit Performance

As we discussed above, we think Ohki Healthcare HoldingsLtd's earnings were not supported by free cash flow, which might concern some investors. For this reason, we think that Ohki Healthcare HoldingsLtd's statutory profits may be a bad guide to its underlying earnings power, and might give investors an overly positive impression of the company. But the good news is that its EPS growth over the last three years has been very impressive. At the end of the day, it's essential to consider more than just the factors above, if you want to understand the company properly. If you want to do dive deeper into Ohki Healthcare HoldingsLtd, you'd also look into what risks it is currently facing. To that end, you should learn about the 3 warning signs we've spotted with Ohki Healthcare HoldingsLtd (including 2 which are significant).

This note has only looked at a single factor that sheds light on the nature of Ohki Healthcare HoldingsLtd's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:3417

Ohki Healthcare HoldingsLtd

Engages in the manufacture and sale of pharmaceuticals and other products.

Adequate balance sheet average dividend payer.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.675.1% undervalued
12 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.2535.6% undervalued
15 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2690.3% undervalued
6 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3410.2% undervalued
3 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

AL
alexbarongo
CRDB logo
alexbarongo on CRDB Bank ·

Critical analysis of CRDB Bank Tanzania (DSE: CRDB).CRDB Bank Tanzania — Critical Investment Analysis

Fair Value:TSh2.59k15.0% overvalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CG
BLCO logo
CG86 on Bausch + Lomb ·

$BLCO & $COO The Silence BEFORE the AGM: A Retail Investor’s Timeline, Findings, and Opinion on SUSPICIOUS SILENCE!

Fair Value:US$39.2357.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
9628 logo
AstrisCorporateAdvisory on SAN Holdings ·

Forging ahead with an ambitious growth plan

Fair Value:JP¥1.92k28.6% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3950.5% undervalued
45 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
RO
Robbo
TSLA logo
Robbo on Tesla ·

The academically fascinating Tesla

Fair Value:US$301.1k% overvalued
38 users have followed this narrative
11 users have commented on this narrative
32 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3133.1% undervalued
1357 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative